CD274 and gastric cancer: Besides, Derks reported enrichment of interferon-γ driven gene signature in EBVaGC and the amplification of PD-L1 in EBVaGC cells was significantly greater than that in other GC subtypes, which also implies that EBVaGC may show greater sensitivity to PD-1/PD-L1 immunotherapy (93).